Navigation Links
Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
Date:5/7/2010

Leading Clinical Research Center Announces State-of-the-Art Overnight Facility

Garden City, NY (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by providing sleep study as well as overnight phase I and bioequivalence capabilities. Accumed, a leading clinical trials facility in Garden City, NY, now offers opportunities for all phases of clinical research with a well-equipped, state-of-the-art overnight facility for conducting clinical trials.

With more than nine years experience in all phases of clinical research studies, Dr. Mitchell Efros explained, “We wanted to become a complete research site and be able to deliver data in all aspects and phases of clinical trial research.” Dr Efros continued, “We expanded to include phase 1 and bioequivalence studies and are able to provide five associated physicians, two Nurse Practitioners as well as a Physician Assistant for our studies.”

Accumed has an extensive research database. Three research coordinators have more than16 years of combined research experience and support staff includes a data manager and regulatory specialist.

Many sponsors as well as contract research organizations (CRO’s) have utilized the expertise of Accumed and Dr. Efros for future direction and consultation. Accumed has over enrolled in more than 90% of recent trials conducted and has been the top enroller in a number of studies with enrollment performance status consistently at more than 95%.

Dr. Efros founded Accumed in 2001 and has successfully conducted more than 100 clinical trials. Accumed has become a well-known research center both in the local community and the industry due to its reputation for extensively trained employees who are dedicated to the highest standards of patient care. The site prepares for all monitoring visits and allots adequate time for the contract research associates (CRAs).

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

Accumed Research Associates (http://www.AccumedResearch.com) is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb3945764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Accumed Research Associates Launches Official Website
2. New research identifies modifiable risk factors for heart disease
3. Nuvo Research announces early redemption of 5% convertible debentures
4. Researcher to track spread of disease, malware and power outages
5. UCSF Researchers Identify Regulator of Human Sperm Cells
6. Octapharma Accepting Applications for Research Grants Through March 31
7. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
8. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
9. University of Maryland chemist receives Astellas Award for blindness prevention research
10. Developing a cyberinfrastructure for comparative effectiveness in cancer research
11. Women should be allowed to eat, drink during labor: Queens University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: